About
Glooko is a powerful remote patient management platform designed to enhance diabetes care through innovative technology. By providing healthcare providers with the tools needed to identify at-risk patients, Glooko supports timely interventions that lead to better health outcomes. The platform integrates seamlessly with various diabetes and biometric devices, ensuring that data flows smoothly between systems and is readily accessible to clinicians. This integration allows for comprehensive population management, giving providers the insights they need to deliver tailored care solutions effectively.
Highlights
One of the standout features of Glooko is its economic value proposition. Providers can utilize five approved CPT codes to facilitate remote monitoring, resulting in potential reimbursements of up to $166 per patient, per month. The platform has shown proven results, with an impressive 18% reduction in average blood glucose levels within three months of use, a 0.8 point drop in HbA1c, and a 12.3% decrease in hyperglycemic events. Furthermore, these outcomes are not only achieved but sustained over a twelve-month period, highlighting Glooko's effectiveness in ongoing patient management. With a reach that extends to over 8,000 clinics across more than 30 countries and a commitment to data security and privacy, Glooko exemplifies trust and reliability in health tech wearables. Healthcare professionals around the world depend on Glooko to improve patient engagement and healthcare delivery, making it an essential tool for modern diabetes management.